(PharmaNewsWire.Com, April 20, 2017 ) As per the syndicated report published by Market Data Forecast Europe Clinical Trials Market which is estimated to be USD 3.98 billion in 2016 is poised to reach USD 5.61 billion by 2021, at a CAGR of 7.10% from 2016 to 2021.
It can attribute to the factors such as support from the respective government bodies regarding the smooth performance of clinical trials, advantages such as boosted the alliances between the pharma-biotech companies and the clinical research organizations and availability of skilled practitioners. But, the market growth can be hindered due to tight R&D budgets in pharma-biotech industry and stringent regulations, which forced companies to move to East.
Clinical trials are experiments done in clinical research. Such behavioral research or prospective biomedical studies on human participants are designed to answer specific questions about behavioral or biomedical interventions, including known interventions and new treatments that warrant further study and comparison. Clinical trials generate data on efficacy and safety.
Europe Clinical Trials Market is segmented based on Phase, Design and Indication as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Phases: Introduction Phase I Phase II Phase III Y-o-Y Growth Analysis, By Phases Market Attractiveness Analysis, By Phases Market Share Analysis, By Phases Based on Design: Introduction Interventional trials Observational trials Expanded Access trials Y-o-Y Growth Analysis, By Design Market Attractiveness Analysis, By Design Market Share Analysis, By Design Based on Indications: Introduction Autoimmune Blood disorders Cancer Circulatory CNS Congenital CVS Dermatology Ear Gastrointestinal Genitourinary Infections Mental disorders Metabolic Musculoskeletal Nose Ophthalmology Y-o-Y Growth Analysis, By Indications Market Attractiveness Analysis, By Indications Market Share Analysis, By Indications
Geographically, Europe market for Clinical Trials is segmented into U.K., Germany, France, Spain and Italy. Europe is the second biggest market in terms of market share across the globe. The awareness of its potential and spread of analytics are increasing at a swift rate in Europe. In the European region, Germany held the largest number of clinical trials due to minimum R&D costs involved when compared to other markets.
The key players in Europe Clinical Trials Market are Chiltern, PPD, ICON Plc, Omnicare, Parexel, Quintles, Kendle, and Charles River
Over the course of recent years, as the number of newly registered clinical trials has increased, we see an estimated growth in Phases I and II studies. Interestingly, and maybe logically, the number of Phase III studies has declined. Along with this move to earlier phase studies, we also see a change in the geographical placement of studies by phase.
The biggest increase (of 82%) occurred in Phase I studies, Phase II expanded by 21% and Phase III declined 10%. Post-marketing Phase IV studies went up by 19%. The Clinical Trials Market study offers the following deliverables: Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market Checkout other related studies in the Pharmaceuticals Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
